Komori
Fuji Pharma (4554) · FactRestated

Three-pronged policy under the Comprehensive Strategy to Strengthen the Pharmaceutical Industry

First written in FY2017-Q1. 3 of 4 entries say "Restated". Latest entry: FY2017.

4entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY20172017: 42017
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2017RestatedAnnual report

    「The Ministry of Health, Labour and Welfare announced the Comprehensive Strategy to Strengthen the Pharmaceutical Industry, a comprehensive strategy to strengthen the industry's competitiveness in order to achieve, as part of the transition to an era of 80% generic drug use, the stable supply of high-quality pharmaceuticals to the public, more efficient healthcare spending and stronger industrial competitiveness as an integrated set of objectives.」

    Continues to describe the government's three-pronged policy without change.
  2. FY2017-Q3RestatedAnnual report

    「The Ministry of Health, Labour and Welfare announced the Comprehensive Strategy to Strengthen the Pharmaceutical Industry, a comprehensive strategy to strengthen the industry's competitiveness in order to achieve, as part of the transition to an era of 80% generic drug use, the stable supply of high-quality pharmaceuticals to the public, more efficient healthcare spending and stronger industrial competitiveness as an integrated set of objectives.」

    Describes the same government strategy as before, advancing stable supply, healthcare cost efficiency and industrial competitiveness as a three-pronged policy.
  3. FY2017-Q2RestatedAnnual report

    「The Ministry of Health, Labour and Welfare announced the Comprehensive Strategy to Strengthen the Pharmaceutical Industry, a comprehensive strategy to strengthen the industry's competitiveness in order to achieve, as part of the transition to an era of 80% generic drug use, the stable supply of high-quality pharmaceuticals to the public, more efficient healthcare spending and stronger industrial competitiveness as an integrated set of objectives.」

    Describes the same government strategy as in the previous quarter, advancing stable supply, healthcare cost efficiency and industrial competitiveness as a three-pronged policy.
  4. FY2017-Q1First statedAnnual report

    「The Ministry of Health, Labour and Welfare announced the Comprehensive Strategy to Strengthen the Pharmaceutical Industry, a comprehensive strategy to strengthen the industry's competitiveness in order to achieve, as part of the transition to an era of 80% generic drug use, the stable supply of high-quality pharmaceuticals to the public, more efficient healthcare spending and stronger industrial competitiveness as an integrated set of objectives.」

    Newly describes the government strategy to advance stable supply, healthcare cost efficiency and industrial competitiveness as a three-pronged policy toward an era in which generic drugs account for 80% of the market.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.